Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Cancer Pain Opioid:

Methadone as a First-Line Opioid in Cancer Pain Management: A Systematic Review. Mercadante S et al. J Pain Symptom Manage. (2018)

The role of tapentadol as a strong opioid in cancer pain management: a systematic and critical review. Mercadante S et al. Curr Med Res Opin. (2017)

Ketamine for cancer pain: what is the evidence? Jonkman K et al. Curr Opin Support Palliat Care. (2017)

Search results

Items: 1 to 20 of 6989

1.

Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis.

McReynolds CB, Hwang SH, Yang J, Wan D, Wagner K, Morisseau C, Li D, Schmidt WK, Hammock BD.

Front Pharmacol. 2019 May 31;10:533. doi: 10.3389/fphar.2019.00533. eCollection 2019.

2.
3.

Prospective Association of Serum Opioid Levels and Clinical Outcomes in Patients With Cancer Pain Treated With Intrathecal Opioid Therapy.

Brogan SE, Sindt JE, Jackman CM, White J, Wilding V, Okifuji A.

Anesth Analg. 2019 Jun 12. doi: 10.1213/ANE.0000000000004276. [Epub ahead of print]

PMID:
31206429
4.

The Current Practice of Opioid for Cancer Dyspnea: The Result from the Nationwide Survey of Japanese Palliative Care Physicians.

Yamaguchi T, Matsunuma R, Suzuki K, Matsuda Y, Mori M, Watanabe H.

J Pain Symptom Manage. 2019 Jun 12. pii: S0885-3924(19)30311-2. doi: 10.1016/j.jpainsymman.2019.06.006. [Epub ahead of print]

PMID:
31201876
5.

Ultrasound-Guided Erector Spinae Plane Block Compared to Modified Pectoral Plane Block for Modified Radical Mastectomy Operations.

Gad M, Abdelwahab K, Abdallah A, Abdelkhalek M, Abdelaziz M.

Anesth Essays Res. 2019 Apr-Jun;13(2):334-339. doi: 10.4103/aer.AER_77_19.

6.

Cancer-Related Pain Is an Independent Predictor of In-Hospital Opioid Overdose: A Propensity-Matched Analysis.

Onyeakusi NE, Mukhtar F, Gbadamosi SO, Oshunbade A, Adejumo AC, Olufajo O, Owoh J.

Pain Med. 2019 Jun 14. pii: pnz130. doi: 10.1093/pm/pnz130. [Epub ahead of print]

PMID:
31197321
7.

Dexmedetomidine as an Option for Opioid Refractory Pain in the Hospice Setting.

Mupamombe CT, Luczkiewicz D, Kerr C.

J Palliat Med. 2019 Jun 13. doi: 10.1089/jpm.2019.0035. [Epub ahead of print]

PMID:
31194614
8.

Efficacy and safety of sustained-release oxycodone compared with immediate-release morphine for pain titration in cancer patients: A multicenter, open-label, randomized controlled trial (SOCIAL).

Pan H, Shen P, Shu Q, Lu L, Qian S, Zhou Y, Han F, Guo Q, Yang Z, Pan J, Xu Q, Zhang P, Wang K.

Medicine (Baltimore). 2019 Jun;98(24):e15505. doi: 10.1097/MD.0000000000015505.

9.

Tapentadol in the management of cancer pain: current evidence and future perspectives.

Kress HG, Coluzzi F.

J Pain Res. 2019 May 16;12:1553-1560. doi: 10.2147/JPR.S191543. eCollection 2019. Review.

10.

Pharmacological rationale for tapentadol therapy: a review of new evidence.

Romualdi P, Grilli M, Canonico PL, Collino M, Dickenson AH.

J Pain Res. 2019 May 16;12:1513-1520. doi: 10.2147/JPR.S190160. eCollection 2019. Review.

11.

The effects of epidural anaesthesia and analgesia on T lymphocytes differentiation markers and cytokines in patients after gastric cancer resection.

Wang L, Liang S, Chen H, Xu Y, Wang Y.

BMC Anesthesiol. 2019 Jun 12;19(1):102. doi: 10.1186/s12871-019-0778-7.

12.

Synergistic symptom-specific effects of ketorolac-tramadol and ketorolac-pregabalin in a rat model of peripheral neuropathy.

Lin WY, Cheng YT, Huang YH, Lin FS, Sun WZ, Yen CT.

J Chin Med Assoc. 2019 Jun;82(6):457-463. doi: 10.1097/JCMA.0000000000000115.

PMID:
31180945
13.

[Treatment of mucositis pain: News and prospects].

Guerrini-Rousseau L, Marec-Berard P, Bolle S, Laurent S.

Bull Cancer. 2019 Jun 6. pii: S0007-4551(19)30198-5. doi: 10.1016/j.bulcan.2019.03.022. [Epub ahead of print] Review. French.

PMID:
31178070
14.

Clinical and Demographic Predictors of Interdisciplinary Chronic Pain Rehabilitation Program Treatment Response.

Huffman KL, Mandell D, Lehmann JK, Jimenez X, Lapin BR.

J Pain. 2019 Jun 5. pii: S1526-5900(18)31038-1. doi: 10.1016/j.jpain.2019.05.014. [Epub ahead of print]

PMID:
31175957
15.

[Opioids for Cancer Pain and its Use under Particular Conditions: A Narrative Review].

Vieira C, Brás M, Fragoso M.

Acta Med Port. 2019 May 31;32(5):388-399. doi: 10.20344/amp.10500. Epub 2019 May 31. Review. Portuguese.

16.

Reduction in opioid use and postoperative pain scores after elective laparotomy with implementation of enhanced recovery after surgery protocol on a gynecologic oncology service.

Schwartz AR, Lim S, Broadwater G, Cobb L, Valea F, Marosky Thacker J, Habib A, Havrilesky L.

Int J Gynecol Cancer. 2019 Jun;29(5):935-943. doi: 10.1136/ijgc-2018-000131. Epub 2019 May 2.

PMID:
31155518
17.

Intranasal therapy with opioids for children and adolescents with cancer: results from clinical studies.

Triarico S, Capozza MA, Mastrangelo S, Attinà G, Maurizi P, Ruggiero A.

Support Care Cancer. 2019 Jun 1. doi: 10.1007/s00520-019-04854-6. [Epub ahead of print] Review.

PMID:
31154533
18.

Cebranopadol, a novel first-in-class analgesic drug candidate: first experience with cancer-related pain for up to 26 weeks.

Koch ED, Kapanadze S, Eerdekens MH, Kralidis G, Letal J, Sabatschus I, Ahmedzai SH.

J Pain Symptom Manage. 2019 May 29. pii: S0885-3924(19)30294-5. doi: 10.1016/j.jpainsymman.2019.05.012. [Epub ahead of print]

PMID:
31152783
19.

Dancing with Deterrents: Understanding the Role of Abuse-Deterrent Opioid Formulations and Naloxone in Managing Cancer Pain.

Mitchell MT.

Oncologist. 2019 May 31. pii: theoncologist.2019-0340. doi: 10.1634/theoncologist.2019-0340. [Epub ahead of print]

PMID:
31152083
20.

Navigating Challenging Conversations About Nonmedical Opioid Use in the Context of Oncology.

Sager Z, Childers J.

Oncologist. 2019 May 31. pii: theoncologist.2019-0277. doi: 10.1634/theoncologist.2019-0277. [Epub ahead of print]

PMID:
31152081

Supplemental Content

Loading ...
Support Center